Following the impressive performances recorded across board in 2020FY, players in the healthcare sector have continue to deliver significant topline growth driven by increased health consciousness of the populace which was induced by the coronavirus pandemic outbreak. FIDSON recorded even stronger performances across all its major business lines in 2021FY, attributable to the improved volume sales volumes and product price increments.
You May Also Like
Earnings Update – LIVESTOCK Q1 2022 Profitability Hampered by Rising Cost
- May 20, 2022
LIVESTOCK’s topline grew by 8.32% YoY to NGN3.64bn in Q1:2022 from NGN3.36bn in Q1:2021. The double-digit growth recorded…
Earnings Update | INTBREW | 2020FY
- April 1, 2021
International Breweries Plc. (INTBREW) managed to sustain its upward revenue trajectory, after a shaky start to the 2020…
Earnings Update- DANGCEM | 2022FY Strong Q4 Performance Supports Earnings
- March 13, 2023
Strong Q4 performance supports Dangote Cement Plc’s (DANGCEM) earnings in 2022FY despite the decline in profitability witnessed in…
Earnings Update | NESTLE | 2020FY
- March 8, 2021
Nestle Nigeria Plc. (NESTLE) reported slower than expected sales growth in Q4:2020, missing our full year revenue estimates…
Earnings Update- FIDSON 2022 FY Improved Sales Volume and Pricing Strategy Anchor Performance.
- April 11, 2023
In line with our expectations, 2022FY marked a continuation of the revenue expansion theme sustained since 2020FY. On…
Earnings Update – NB_ 2023FY & Q1_2024
- May 15, 2024
Dear All, Kindly find attached the report. Regards, NB Earnings_Update_2023FY_Q1 2024